Company Page

Asimov builds tools to program living cells by integrating mammalian synthetic biology, computer-aided design, and machine learning. The company provides an end-to-end platform for genetic design to advance the design and manufacture of biologics, cell therapies, gene therapies, and RNA therapeutics. Founded by bioengineers from MIT and Boston University, Asimov offers proprietary cell lines, software for genetic design, and a catalog of engineered genetic systems to pharmaceutical companies and CDMOs.

Company Founded in 2017

Healthtech & Biotech